Recombinant Human ketohexokinase protein is a Human Full Length protein, in the 1 to 298 aa range, expressed in Escherichia coli, with >90% purity and suitable for SDS-PAGE, MS.
M E E K Q I L C V G L V V L D V I S L V D K Y P K E D S E I R C L S Q R W Q R G G N A S N S C T I L S L L G A P C A F M G S M A P G H V A D F V L D D L R R Y S V D L R Y T V F Q T T G S V P I A T V I I N E A S G S R T I L Y Y D R S L P D V S A T D F E K V D L T Q F K W I H I E G R N A S E Q V K M L Q R I D A H N T R Q P P E Q K I R V S V E V E K P R E E L F Q L F G Y G D V V F V S K D V A K H L G F Q S A E E A L R G L Y G R V R K G A V L V C A W A E E G A D A L G P D G K L L H S D A F P P P R V V D T L G A G D T F N A S V I F S L S Q G R S V Q E A L R F G C Q V A G K K C G L Q G F D G I V
Application | Reactivity | Dilution info | Notes |
---|---|---|---|
Application SDS-PAGE | Reactivity Reacts | Dilution info - | Notes - |
Application MS | Reactivity Reacts | Dilution info - | Notes - |
Select an associated product type
Catalyzes the phosphorylation of the ketose sugar fructose to fructose-1-phosphate.
Ketohexokinase, Hepatic fructokinase, KHK
Recombinant Human ketohexokinase protein is a Human Full Length protein, in the 1 to 298 aa range, expressed in Escherichia coli, with >90% purity and suitable for SDS-PAGE, MS.
pH: 7.4
Constituents: PBS, 10% Glycerol (glycerin, glycerine)
ab95395 is purified using conventional chromatography techniques.
Catalyzes the phosphorylation of the ketose sugar fructose to fructose-1-phosphate.
Belongs to the carbohydrate kinase PfkB family.
Ketohexokinase also known as KHK or fructokinase is an enzyme that catalyzes the phosphorylation of fructose to fructose-1-phosphate utilizing ATP in the process. This enzyme has two isoforms: KHK-C and KHK-A with the cytosolic form (KHK-C) being approximately 35 kDa in mass. KHK is expressed at high levels in the liver kidney cortex and small intestine showing its importance for fructose metabolism in these tissues. The liver in particular exhibits extensive expression which facilitates the initial step in fructose metabolism.
Ketohexokinase plays a significant role in the initial stage of fructose metabolism by converting fructose to fructose-1-phosphate. This reaction is a part of the fructose metabolic pathway enabling the use of fructose as an energy source especially in hepatocytes. KHK operates as a monomer and does not form part of any larger protein complex. The enzyme importantly controls the rate of fructose utilization preventing accumulation of free fructose which could lead to metabolic issues.
Ketohexokinase belongs to the fructose metabolism pathway which is a subset of the larger carbohydrate metabolism. This enzyme's product fructose-1-phosphate subsequently interacts with aldolase B which is involved in further steps of the glycolysis and gluconeogenesis pathways. Besides aldolase B ketohexokinase's activity influences the balance between fructose and glucose metabolism connecting fructolysis with glycolytic and gluconeogenic pathways.
Dysfunction of ketohexokinase has been linked to hereditary fructose intolerance a condition resulting from a deficiency of aldolase B where the accumulation of fructose-1-phosphate can cause liver damage and hypoglycemia. KHK has also been implicated in metabolic syndrome where excessive fructose consumption exacerbates conditions like insulin resistance and fatty liver disease. The relationship of KHK with metabolic syndrome highlights its interaction with insulin pathways which involves proteins such as insulin receptor substrates that are affected by altered fructose metabolism.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
15% SDS-PAGE showing ab95395 at approximately 32.7kDa (3μg).
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com